Bio-Rad Laboratories Operating Margin 2010-2023 | BIO.B

Current and historical operating margin for Bio-Rad Laboratories (BIO.B) over the last 10 years. The current operating profit margin for Bio-Rad Laboratories as of March 31, 2023 is 13.57%.
Bio-Rad Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2023-03-31 $2.78B $0.40B 14.32%
2022-12-31 $2.80B $0.48B 17.20%
2022-09-30 $2.81B $0.48B 17.01%
2022-06-30 $2.87B $0.54B 18.84%
2022-03-31 $2.90B $0.55B 18.85%
2021-12-31 $2.92B $0.50B 17.14%
2021-09-30 $2.98B $0.57B 19.09%
2021-06-30 $2.88B $0.52B 18.13%
2021-03-31 $2.70B $0.45B 16.62%
2020-12-31 $2.55B $0.42B 16.58%
2020-09-30 $2.38B $0.30B 12.39%
2020-06-30 $2.29B $0.24B 10.55%
2020-03-31 $2.33B $0.25B 10.56%
2019-12-31 $2.31B $0.23B 9.90%
2019-09-30 $2.31B $-0.06B -2.47%
2019-06-30 $2.29B $-0.08B -3.41%
2019-03-31 $2.29B $-0.09B -3.93%
2018-12-31 $2.29B $-0.10B -4.50%
2018-09-30 $2.29B $0.18B 7.85%
2018-06-30 $2.28B $0.18B 8.02%
2018-03-31 $2.21B $0.14B 6.19%
2017-12-31 $2.16B $0.12B 5.51%
2017-09-30 $2.11B $0.04B 1.99%
2017-06-30 $2.09B $0.03B 1.49%
2017-03-31 $2.10B $0.06B 2.67%
2016-12-31 $2.07B $0.06B 2.71%
2016-09-30 $2.07B $0.14B 6.58%
2016-06-30 $2.03B $0.14B 6.95%
2016-03-31 $2.02B $0.16B 7.83%
2015-12-31 $2.02B $0.17B 8.22%
2015-09-30 $2.05B $0.16B 7.72%
2015-06-30 $2.11B $0.16B 7.50%
2015-03-31 $2.14B $0.16B 7.67%
2014-12-31 $2.18B $0.15B 6.90%
2014-09-30 $2.18B $0.15B 6.93%
2014-06-30 $2.15B $0.15B 6.82%
2014-03-31 $2.14B $0.15B 7.19%
2013-12-31 $2.13B $0.17B 7.92%
2013-09-30 $2.10B $0.19B 8.94%
2013-06-30 $2.10B $0.23B 10.72%
2013-03-31 $2.08B $0.25B 11.76%
2012-12-31 $2.07B $0.26B 12.76%
2012-09-30 $2.05B $0.29B 14.13%
2012-06-30 $2.06B $0.30B 14.40%
2012-03-31 $2.08B $0.29B 14.07%
2011-12-31 $2.07B $0.31B 14.71%
2011-09-30 $2.06B $0.29B 13.95%
2011-06-30 $2.01B $0.29B 14.31%
2011-03-31 $1.96B $0.29B 14.70%
2010-12-31 $1.93B $0.28B 14.73%
2010-09-30 $1.89B $0.26B 13.87%
2010-06-30 $1.88B $0.25B 13.53%
2010-03-31 $1.84B $0.24B 13.17%
2009-12-31 $1.78B $0.23B 12.89%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.988B $2.802B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $138.614B 8.47
GSK (GSK) United Kingdom $70.187B 9.79
QIAGEN (QGEN) Netherlands $10.454B 22.07
Ginkgo Bioworks Holdings (DNA) United States $3.441B 0.00
Arcus Biosciences (RCUS) United States $1.502B 0.00
Biohaven (BHVN) United States $1.477B 0.00
Emergent Biosolutions (EBS) United States $0.399B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.200B 0.00
Enzo Biochem (ENZ) United States $0.110B 0.00
SQZ Biotechnologies (SQZ) United States $0.017B 0.00